Literature DB >> 6794929

Sites of prostaglandin synthesis in the bovine heart and isolated bovine coronary microvessels.

M E Gerritsen, M P Printz.   

Abstract

Metabolically active coronary microvessels (generally less than 100 micrometers in diameter) were isolated from bovine hearts. These preparations were virtually free of contaminating myocytes and consisted of a mixture of arterioles, venules, capillaries, and collagen fibers. The prostaglandin biosynthetic capacity of isolated coronary microvessels was assessed by quantitating conversion of 14C-arachidonic acid and 14C-prostaglandin endoperoxide (PGH2) to prostaglandins. Coronary microvessels were found to exhibit low cyclooxygenase activity, i.e., minimal conversion (less than 1%) of arachidonic acid (AA) to prostaglandins when compared with either the coronary artery (3.6% conversion of AA) or coronary vein (3.3%). Isolated myofibril fractions demonstrated virtually no cyclooxygenase activity (less than 0.1%). Two enzymatic endoperoxide metabolizing activities were evident in the microvessels, prostacyclin synthetase and PGE isomerase. When compared on a microsomal protein basis, the coronary artery exhibited higher prostacyclin synthetase activity than the microvessels but was devoid of PGE isomerase activity. In contrast, whereas PGE isomerase activity was detectable in the coronary vein, the activity was lower than that of the microvessels; further, it could not be demonstrated in the other myocardial fractions. A glutathione-enhanced PGD-forming activity was present in high speed supernatants derived from the coronary artery and vein preparations, but was not present in the coronary microvessel or isolated myofibril fractions. From these studies we conclude that (1) the major source of prostaglandins released into the coronary circulation is the coronary vasculature, and (2) the resistance elements of the coronary circulation differ from the larger elements (i.e., arteries and veins) in the enzymes of the prostaglandin biosynthetic pathway present and thus in the nature and perhaps quantity of prostaglandins biosynthesized.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6794929     DOI: 10.1161/01.res.49.5.1152

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  13 in total

1.  Phenotypic diversity in cultured cerebral microvascular endothelial cells.

Authors:  M A Rupnick; A Carey; S K Williams
Journal:  In Vitro Cell Dev Biol       Date:  1988-05

2.  Remodeling of Wall Mechanics and the Myogenic Mechanism of Rat Intramural Coronary Arterioles in Response to a Short-Term Daily Exercise Program: Role of Endothelial Factors.

Authors:  Mária Szekeres; György L Nádasy; Gabriella Dörnyei; Annamária Szénási; Akos Koller
Journal:  J Vasc Res       Date:  2018-02-14       Impact factor: 1.934

Review 3.  Prostaglandins, other eicosanoids and endothelial cells.

Authors:  K Schrör
Journal:  Basic Res Cardiol       Date:  1985 Sep-Oct       Impact factor: 17.165

4.  Regional heterogeneity of endothelium-dependent vasodilatation in the rabbit kidney.

Authors:  H S Cairns; M E Rogerson; J Westwick; G H Neild
Journal:  J Physiol       Date:  1991-05       Impact factor: 5.182

5.  Potential mechanisms of low-sodium diet-induced cardiac disease: superoxide-NO in the heart.

Authors:  Nobuhiro Suematsu; Caroline Ojaimi; Fabio A Recchia; Zipping Wang; Yester Skayian; Xiaobin Xu; Suhua Zhang; Pawel M Kaminski; Dong Sun; Michael S Wolin; Gabor Kaley; Thomas H Hintze
Journal:  Circ Res       Date:  2009-12-10       Impact factor: 17.367

6.  Prostaglandin formation from exogenous precursor in homogenates of human cardiac tissue.

Authors:  R Brandt; J Nowak; T Sonnenfeld
Journal:  Basic Res Cardiol       Date:  1984 Mar-Apr       Impact factor: 17.165

7.  Identification of 13,14-dihydro-15-oxo-prostaglandin F2 alpha in the circulation during infusions of bradykinin and prostaglandin E2 in man.

Authors:  S E Barrow; J Cockcroft; C T Dollery; N E Hickling; J M Ritter
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

8.  Arachidonic acid and prostaglandin endoperoxide metabolism in isolated rabbit and coronary microvessels and isolated and cultivated coronary microvessel endothelial cells.

Authors:  M E Gerritsen; C D Cheli
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

9.  Disturbed lipid metabolism in diabetic coronary vessels.

Authors:  M Z Koltai; P Rösen; P Hadházy; Z Aranyi; G Ballagi-Pordány; G Pogátsa
Journal:  Mol Cell Biochem       Date:  1992-02-12       Impact factor: 3.396

10.  Preservation of NO production by statins in the treatment of heart failure.

Authors:  Jean-Noel Trochu; Seema Mital; Xiao ping Zhang; Xiaobin Xu; Manuel Ochoa; James K Liao; Fabio A Recchia; Thomas H Hintze
Journal:  Cardiovasc Res       Date:  2003-11-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.